B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PRMT1

MOLECULAR TARGET

protein arginine methyltransferase 1

UniProt: AAH19268NCBI Gene: 327617 compounds

PRMT1 (protein arginine methyltransferase 1) is targeted by 17 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PRMT1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1s adenosylhomocysteine1.956
2Disulfiram1.102
3pentamidine1.102
4Riboflavin Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables.1.102
5Sulfinpyrazone1.102
6myricetin-3-O-galactopyranoside [Supplementary Concept]0.691
7Calcimycin0.691
8cefaclor0.691
9Cefixime0.691
10Cefotetan0.691
11Demeclocycline0.691
12Ethidium0.691
13hydroxyindoleacetic acid0.691
14Metergoline0.691
15Nisoldipine0.691
16Nitrofurantoin0.691
17Suramin0.691

About PRMT1 as a Drug Target

PRMT1 (protein arginine methyltransferase 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 17 compounds with documented PRMT1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PRMT1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.